Fresenius Kabi

News

EU has its first RoActemra biosimilar, from Fresenius Kabi

The European Commission has approved the first biosimilar version of Actemra/RoActemra, Roche’s $3 billion blockbuster, from German drugmaker Fresenius Kabi.

News

Fresenius' new CEO starts strategic review as pressure rises

When Michael Sen took over as chief executive of Fresenius at the start of this month, he knew he was facing some big challenges.

News

Deals build Fresenius Kabi's position in biosimilars, medtec...

German injectable medicines specialist Fresenius Kabi has made a pair of deals to kickstart its new strategic direction, including a majority stake in mAbxience that bolsters its position i

News

Pharma sales rep talking to a GP over video conferencing

Study finds Germany trails Spain and the US in digital healt...

Germany is lagging behind other countries in the adoption of digital health, including Spain and the US, according to a new survey carried out on behalf of drugmaker Fresenius.

News